These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 27317188

  • 1. Efficacy and Safety of Once-Daily Extended-Release (ER) Hydrocodone in Individuals Previously Receiving ER Morphine for Chronic Pain.
    Broglio K, Pergolizzi J, Kowalski M, Lynch SY, He E, Wen W.
    Pain Pract; 2017 Mar; 17(3):382-391. PubMed ID: 27317188
    [Abstract] [Full Text] [Related]

  • 2. Long-term safety and effectiveness of once-daily, single-entity, extended-release hydrocodone over 76 weeks of an open-label study in patients with chronic noncancer and nonneuropathic pain.
    Taber L, Lynch SY, He E, Ripa SR.
    Postgrad Med; 2016 Jan; 128(1):23-33. PubMed ID: 26681111
    [Abstract] [Full Text] [Related]

  • 3. 12-Month safety and effectiveness of once-daily hydrocodone tablets formulated with abuse-deterrent properties in patients with moderate to severe chronic pain.
    Wen W, Taber L, Lynch SY, He E, Ripa S.
    J Opioid Manag; 2015 Jan; 11(4):339-56. PubMed ID: 26312961
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of once-daily, extended-release hydrocodone in individuals previously receiving hydrocodone/acetaminophen combination therapy for chronic pain.
    Bartoli A, Michna E, He E, Wen W.
    Postgrad Med; 2015 Jan; 127(1):5-12. PubMed ID: 25526227
    [Abstract] [Full Text] [Related]

  • 5. Hysingla® ER, a once-daily, single-entity hydrocodone with abuse-deterrent properties in treating chronic nonmalignant and nonneuropathic pain in patients with osteoarthritis.
    Taber L, Baldridge S, He E, Ripa SR.
    Postgrad Med; 2017 Jan; 129(1):133-139. PubMed ID: 27983881
    [Abstract] [Full Text] [Related]

  • 6. Six-month, open-label study of hydrocodone extended release formulated with abuse-deterrence technology: Safety, maintenance of analgesia, and abuse potential.
    Hale ME, Ma Y, Malamut R.
    J Opioid Manag; 2016 Jan; 12(2):139-47. PubMed ID: 27194199
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness and Safety of Once-Daily Extended-Release Hydrocodone in Individuals Previously Receiving Immediate-Release Oxycodone for Chronic Pain.
    Pergolizzi J, Kowalski M, He E.
    Pain Med; 2018 May 01; 19(5):967-977. PubMed ID: 28371835
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of Quality of Life, Functioning, Disability, and Work/School Productivity Following Treatment with an Extended-Release Hydrocodone Tablet Formulated with Abuse-Deterrence Technology: A 12-month Open-label Study in Patients with Chronic Pain.
    Hale ME, Zimmerman TR, Ma Y, Malamut R.
    Pain Pract; 2017 Feb 01; 17(2):229-238. PubMed ID: 26857424
    [Abstract] [Full Text] [Related]

  • 10. Safety and effectiveness of once-daily Hysingla extended-release tablets in patients with baseline depression or anxiety.
    Taber L, He E, Ripa SR.
    Pain Manag; 2017 Nov 01; 7(6):473-488. PubMed ID: 28747087
    [Abstract] [Full Text] [Related]

  • 11. Relationship between change in pain intensity and functional outcomes in patients with chronic pain receiving twice daily extended-release hydrocodone bitartrate.
    Argoff C, Arnstein P, Stanos S, Robinson CY, Galer BS, Gould E, Gammaitoni A.
    J Opioid Manag; 2015 Nov 01; 11(5):417-24. PubMed ID: 26535969
    [Abstract] [Full Text] [Related]

  • 12. Long-term effectiveness and safety of once-daily, single-entity, extended-release hydrocodone in patients of ≥75 years of age with moderate to severe nonmalignant and nonneuropathic pain.
    Broglio K, Pergolizzi J, Kowalski M, Lynch SY, He E, Wen W.
    Geriatr Nurs; 2017 Nov 01; 38(1):39-47. PubMed ID: 27502432
    [Abstract] [Full Text] [Related]

  • 13. An Analysis of Rescue Medication Utilization from a 3-Month, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Chronic Low Back Pain Treated with Single-Entity, Twice-Daily, Extended-Release Hydrocodone.
    Nalamachu S, deLeon-Casasola OA, Robinson CY, Galer BS, Gould E, Gammaitoni A.
    Pain Med; 2015 Dec 01; 16(12):2338-43. PubMed ID: 26301791
    [Abstract] [Full Text] [Related]

  • 14. Randomized, double-blind, placebo-controlled study of the efficacy and safety of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen tablets for acute postoperative pain.
    Singla N, Margulis R, Kostenbader K, Zheng Y, Barrett T, Giuliani MJ, Chen Y, Young JL.
    Phys Sportsmed; 2015 May 01; 43(2):126-37. PubMed ID: 25796986
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intranasal Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users.
    Harris SC, Cipriano A, Colucci SV, Kapil RP, Geoffroy P, Hopyan T, Levy-Cooperman N.
    Pain Med; 2016 May 01; 17(5):820-31. PubMed ID: 26814240
    [Abstract] [Full Text] [Related]

  • 18. Twelve-month, open-label assessment of long-term safety and abuse potential of hydrocodone extended-release formulated with abuse-deterrence technology in patients with chronic pain.
    Hale ME, Zimmerman TR, Ma Y, Malamut R.
    J Opioid Manag; 2015 May 01; 11(5):425-34. PubMed ID: 26535970
    [Abstract] [Full Text] [Related]

  • 19. Single-entity hydrocodone extended-release capsules in opioid-tolerant subjects with moderate-to-severe chronic low back pain: a randomized double-blind, placebo-controlled study.
    Rauck RL, Nalamachu S, Wild JE, Walker GS, Robinson CY, Davis CS, Farr SJ.
    Pain Med; 2014 Jun 01; 15(6):975-85. PubMed ID: 24517082
    [Abstract] [Full Text] [Related]

  • 20. Tolerability of Biphasic-Release Hydrocodone Bitartrate/Acetaminophen Tablets (MNK-155): A Phase III, Multicenter, Open-Label Study in Patients With Osteoarthritis or Chronic Low Back Pain.
    Zheng Y, Kostenbader K, Barrett T, Hisaw E, Giuliani MJ, Chen Y, Young JL.
    Clin Ther; 2015 Jun 01; 37(6):1235-47. PubMed ID: 25913923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.